NEW YORK, May 19, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place from May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin. The AAES Annual Meeting, a premier academic and clinical forum, convenes leading endocrine surgeons, researchers, and innovators globally to explore advancements in endocrine

NEW YORK, May 12, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a leader in Microwave Ablation (MWA) technology, recently hosted an advanced training session and academic exchange in New Orleans, reinforcing its commitment to clinical innovation and research collaboration in minimally invasive thyroid therapies. The program was led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, a leading figure in thyroid ablation and endocrine surgery. He was joined by Dr.

NEW YORK, May 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin. The AAES Annual Meeting is widely regarded as the premier gathering of endocrine surgeons in North America, convening leading experts, clinicians, researchers, and trainees in the

NEW YORK, May 5, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 2025 Combined Otolaryngology Spring Meetings (COSM), taking place May 14-18, 2025, in New Orleans, Louisiana. COSM is internationally recognized as one of the foremost meetings globally for the otolaryngology-head and neck surgery community. By convening multiple leading otolaryngology societies, the conference serves as a comprehe

NEW YORK, April 28, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a leader in Microwave Ablation (MWA) technology, recently hosted an advanced MWA training session in New Orleans, reinforcing its commitment to expanding global expertise in minimally invasive therapies. The program, led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, provided specialized training to Dr. Shahzad Ahmad, a distinguished endocrinologist and thyroid specialist from Salt Lake City.

NEW YORK, April 24, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company") proudly welcomed a delegation of leading thyroid specialists from Malaysia for an intensive clinical training and academic exchange at the Eighth Affiliated Hospital of Sun Yat-sen University and Shenzhen People's Hospital in Shenzhen, China. The program underscores Baird Medical's commitment to promoting global collaboration and advancing clinical excellence in microwave ablation (MWA) for thyroid disease. Participating physicians engaged in an inte

NEW YORK, April 14, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company") recently hosted Dr. Gary G. Tse, a distinguished interventional radiologist from UCLA Health, for an immersive clinical visit in Guangzhou, China. The visit highlighted Baird Medical's cutting-edge microwave ablation (MWA) technology and its growing role in minimally invasive thyroid treatments. Dr. Tse observed multiple thyroid nodule ablation procedures at Sun Yat-sen University Cancer Center, gaining valuable insights into the precision and clinic

NEW YORK, April 9, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company") recently announced a significant milestone in its international expansion. The U.S. Food and Drug Administration (FDA) has issued a Certificate to Foreign Government (CFG) to the Egyptian regulatory authorities, affirming the company's compliance with U.S. medical device standards and facilitating its market entry into Egypt. Simultaneously, Baird Medical has formally submitted regulatory registration applications in Egypt, Hong Kong, Thailand, Malaysia, Kazakhstan, Sri Lanka, and India. The Company anticipates timely approvals in these key markets, further accelera

NEW YORK, April 2, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company") proudly hosted Dr. Quan-Yang Duh, a world-renowned endocrine surgeon and Chief of Endocrine Surgery at the University of California, San Francisco (UCSF), for an in-depth clinical observation visit in Guangzhou and Shenzhen, China. During his visit, Dr. Duh closely examined the real-world application of Baird Medical's advanced microwave ablation (MWA) technology. In Guangzhou, Dr. Duh visited several prestigious hospitals, where he observed a range o

NEW YORK, March 31, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company") proudly announces the successful utilization of its advanced microwave ablation (MWA) technology in two recent endocrine procedures . These procedures were performed by Dr. Saka Kazeem, MD, a distinguished endocrinologist with over 30 years of clinical experience. Using Baird Medical's MWA system for the first time, Dr. Kazeem praised its efficiency and seamless integration into clinical practice. "The system is both intuitive and optimizes procedur

20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

NT 20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

S-8 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

20FR12B - Baird Medical Investment Holdings Ltd (0001982444) (Filer)